04.26.2023
Prevent & Delay
$581,612.00
24 months
Induction of peripheral tolerance to beta cell antigens by specific targeting of Langerin+ Dendritic Cells
Funds to support preclinical studies to develop a new targeted immunotherapy for type 1 diabetes.